Shared on 05 Sep 25
Robust Registration Pipeline Will Unlock Further Market Expansion
With no notable changes in the Discount Rate or Future P/E, the consensus Analyst Price Target for Sharda Cropchem remains stable at ₹1128. What's in the News Sharda Cropchem scheduled a board meeting to consider and approve the unaudited financial results for the quarter ended June 30, 2025.
Shared on 30 Jul 25
Fair value Increased 43%Robust Registration Pipeline Will Unlock Further Market Expansion
The sharp upward revision in Sharda Cropchem's analyst price target reflects stronger expectations for profitability, as shown by a higher net profit margin, and increased valuation confidence, as indicated by a rising future P/E, resulting in a new target of ₹1128. What's in the News Board meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2025.
Shared on 01 May 25
Fair value Decreased 9.87%New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
Shared on 23 Apr 25
New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 14%New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 11%New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 12%New Product Approvals And Strong Cash Reserves Will Drive Future Market Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.